Quick Answer
LEXICON PHARMACEUTICALS, INC. reported Stockholders Equity of $107.54 million for the year ending 2025.
- LEXICON PHARMACEUTICALS, INC. showed a decrease of -26.3% in Stockholders Equity from 2024 to 2025.
- This data is from LEXICON PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $194.19 million | Q3 2011: $169.48 million | Q1 2012: $268.97 million | Q2 2012: $244.90 million | Q3 2012: $252.76 million | Q1 2013: $242.21 million | Q2 2013: $215.08 million | Q3 2013: $185.71 million | Q1 2014: $140.78 million | Q2 2014: $116.67 million | Q3 2014: $77.82 million | Q1 2015: $257.61 million | Q2 2015: $231.47 million | Q3 2015: $197.94 million | Q1 2016: $252.88 million | Q2 2016: $217.33 million | Q3 2016: $185.18 million | Q1 2017: $134.60 million | Q2 2017: $106.31 million | Q3 2017: $78.38 million | Q1 2018: $26.19 million | Q2 2018: -$5.07 million | Q3 2018: -$29.40 million | Q1 2019: -$45.69 million | Q2 2019: -$64.89 million | Q3 2019: $164.71 million | Q1 2020: $54.78 million | Q2 2020: -$10.69 million | Q3 2020: $87.64 million | Q1 2021: $152.55 million | Q2 2021: $137.23 million | Q3 2021: $136.60 million | Q1 2022: $92.70 million | Q2 2022: $70.83 million | Q3 2022: $144.02 million | Q1 2023: $88.05 million | Q2 2023: $186.36 million | Q3 2023: $139.51 million | Q1 2024: $288.87 million | Q2 2024: $239.98 million | Q3 2024: $178.51 million | Q1 2025: $123.03 million | Q2 2025: $129.44 million | Q3 2025: $120.16 million.
- Over the full 16 years of available data (2010 to 2025), LEXICON PHARMACEUTICALS, INC.'s Stockholders Equity has declined by 56.5%.
- Historical annual values: Fiscal year 2025: $107.54 million | Fiscal year 2024: $145.95 million | Fiscal year 2023: $93.11 million | Fiscal year 2022: $117.12 million | Fiscal year 2021: $113.60 million | Fiscal year 2020: $156.37 million | Fiscal year 2019: $117.10 million | Fiscal year 2018: -$26.41 million | Fiscal year 2017: $68.27 million | Fiscal year 2016: $167.51 million | Fiscal year 2015: $285.97 million | Fiscal year 2014: $284.02 million | Fiscal year 2013: $170.16 million | Fiscal year 2012: $266.68 million | Fiscal year 2011: $297.57 million | Fiscal year 2010: $247.02 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: